June 2022

Effectiveness and safety of a direct-to-patient telehealth service providing medication abortion targeted at rural and remote populations: Cross-sectional findings from Marie Stopes Australia

Seymour JW, Melville C, Thompson TA, Grossman D. Contraception. June 2022. DOI: 10.1016/j.contraception.2022.06.010

We assessed the safety and effectiveness of direct-to-patient telehealth provision of medication abortion in Australia.

Study design
We included all medication abortions (January 2017-December 2018) from Marie Stopes Australia's patient management and adverse event reporting systems. We defined effectiveness as whether the patient had a continuing pregnancy, incomplete abortion, and/or subsequent vacuum aspiration or procedural abortion and safety as whether the patient experienced any adverse event.

Direct-to-patient telehealth was more effective than in-clinic provision (97.2% versus 95.4%). The proportion of adverse events did not differ between groups.

This direct-to-patient telehealth service is safe and effective.